48
Views
1
CrossRef citations to date
0
Altmetric
Corrigendum

Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]

Page 9793 | Published online: 11 Dec 2019
This article refers to:
Nanofibrous vildagliptin-eluting stents enhance re-endothelialization and reduce neointimal formation in diabetes: in vitro and in vivo

Lee CH, Hsieh MJ, Chang SH, et al. Int J Nano. 2019;14:7503–7513.

The authors noticed a mistake in the published paper which was overlooked during the revision stages.

On page 7511, in the Acknowledgments section, the sentence “… Chang Gung Memorial Hospital (Contract No. CMRPG3G1291) for financially supporting this research.” should read “… Chang Gung Memorial Hospital (Contract No. CMRPG3G1291 and CMRPG3G1292) for financially supporting this research.”

The authors apologize for this oversight.